Inc Inovo

Inovo, Inc
Product: AccuPulse Model 6505 oxygen conserver, Bonsai Velocity oxygen conserver, Evolution oxygen conserver, Evolution with Motion oxygen conserver, SmartDose oxygen conserver, Smart Does Mini oxygen conserver, Oxymizer Disposable oxygen conservers, and oxygen Regulators.
Date: 2/19/2015

4. Failure to establish and maintain procedures for validating the device design, as required by 21 CFR 820.30(g). Specifically,

a. Your software development /validation:

i. does not include written procedures covering the development/validation of the software used in your devices;

ii. documentation for your Evolution Oxygen Conserver device does not include structural testing at the code level (use of static code checkers, independent code review, etc); and

iii. software product testing procedure, Database/Software Controls IQP 030 Rev A dated 10/20/08, does not require structural testing and does not include provisions for the adequate description of regression testing.

We reviewed your firm?s responses and conclude that they are not fully adequate.

a) The revisions to your software procedures and the initiation of the added testing requirements do not appear to timely relative to the criticality of this deficiency.

FDA District Office: Florida District

Schedule Discussion with John F. Murray, Jr.

John is currently providing telephone and face-to-face meetings to discuss:  Cybersecurity, Part 11, 483 Response, design controls expectations for software documentation, and other topics.

Leave a message and we will contact you to schedule:

Corporate Office

Partners located in the US (CA, FL, MA, MN, TN) and Italy.